Viewing Study NCT03170232


Ignite Creation Date: 2025-12-24 @ 9:32 PM
Ignite Modification Date: 2026-02-19 @ 9:08 AM
Study NCT ID: NCT03170232
Status: TERMINATED
Last Update Posted: 2020-07-31
First Post: 2017-05-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Pilot Study of Danirixin for Disease Progression in Chronic Obstructive Pulmonary Disease (COPD)
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pulmonary Disease, Chronic Obstructive View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HRQoL View
None Disease Progression View
None Danirixin View
None COPD View